Post Reply
121-129 of 129
A possible delisting....
its on halt today!
load up before you are left out
anything under 0.52 is a good buy. tp is more than 60 cents. it has been granted license to manufacture a list of restricted medicines in china and manufacturers like them in china dont grow on trees. they are only around 5 of them in the whole of china. many foreign players are very interested to do biz with them to bring in medicines into china and using c&o as the distributors agent. it has extensive distribution channels or network in china. very good potential
ascending triangle seem to be taking shape on the chart of C&O! Sign of Bullish continuation ???
read my analysis of C&O
Note: I feel it is better to wait until the price breakout then trade. Yes, might not get it at the lowest price but at least safer.
Bro seems like you advertise a lot for this share.
What is the average cost of your C&O? WHat is yr TP to sell?
masterlim ( Date: 29-Nov-2010 21:03) Posted:
|
hopefully news of merger with foreign players or approval of medicines list
unsexy stock with huge potential. only lesser than 5 manufacturers in china are eligible to manufacture a handful list of drugs and medicines.
currently in talk with foreign pharma players on some merger play. i expect news to come out last few weeks but think it is delayed. hopefully before the year end we can see some good news.
C&O Pharmaceutical- Results (Toh wei kiong)
Recommendation: Buy
Previous close: S$0.475
Fair value: S$0.65
· Revenue for 1Q11 was up 2% y-y to HK$128.8m, net profit up 10% y-y to HK$28.3m
· 1Q11 results were within expectations
· Rumours of impending price cuts is not an issue
- Focus on introducing more high quality exclusive drugs into China
· Maintain Buy rating and fair value of S$0.65
Phillip Securities Research Pte Ltd Singapore 15 Nov 2010
/